Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook

overall survival

  • You have access
    QUANTIFICATION OF METASTATIC PROSTATE CANCER WHOLE-BODY TUMOR BURDEN WITH FDG PET PARAMETERS AND ASSOCIATIONS WITH OVERALL SURVIVAL AFTER FIRST LINE ABIRATERONE OR ENZALUTAMIDE: A SINGLE- CENTER RETROSPECTIVE COHORT STUDY
    Andreas G. Wibmer, Michael J. Morris, Mithat Gonen, Junting Zheng, Hedvig Hricak, Steven M. Larson, Howard I. Scher and Hebert Alberto Vargas
    Journal of Nuclear Medicine January 8, 2021, jnumed.120.256602; DOI: https://doi.org/10.2967/jnumed.120.256602
  • You have access
    64Cu-DOTATATE PET/CT and Prediction of Overall and Progression-Free Survival in Patients with Neuroendocrine Neoplasms
    Esben Andreas Carlsen, Camilla Bardram Johnbeck, Tina Binderup, Mathias Loft, Andreas Pfeifer, Jann Mortensen, Peter Oturai, Annika Loft, Anne Kiil Berthelsen, Seppo W. Langer, Ulrich Knigge and Andreas Kjaer
    Journal of Nuclear Medicine October 1, 2020, 61 (10) 1491-1497; DOI: https://doi.org/10.2967/jnumed.119.240143
  • You have access
    First-Line Selective Internal Radiation Therapy in Patients with Uveal Melanoma Metastatic to the Liver
    Alexandre Ponti, Alban Denys, Antonia Digklia, Niklaus Schaefer, Arnaud Hocquelet, Jean-François Knebel, Olivier Michielin, Clarisse Dromain and Rafael Duran
    Journal of Nuclear Medicine March 1, 2020, 61 (3) 350-356; DOI: https://doi.org/10.2967/jnumed.119.230870
  • You have access
    Metabolic Tumor Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma
    Jasmin Mettler, Horst Müller, Conrad-Amadeus Voltin, Christian Baues, Bernd Klaeser, Alden Moccia, Peter Borchmann, Andreas Engert, Georg Kuhnert, Alexander Drzezga, Markus Dietlein and Carsten Kobe
    Journal of Nuclear Medicine February 1, 2019, 60 (2) 207-211; DOI: https://doi.org/10.2967/jnumed.118.210047
  • You have access
    Differentiated Thyroid Cancer Patients More Than 60 Years Old Paradoxically Show an Increased Life Expectancy
    Tobias Markus Maier, Otmar Schober, Joachim Gerß, Dennis Görlich, Christian Wenning, Michael Schaefers, Burkhard Riemann and Alexis Vrachimis
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 190-195; DOI: https://doi.org/10.2967/jnumed.114.150284
  • You have access
    3′-Deoxy-3′-18F-Fluorothymidine PET–Derived Proliferative Volume Predicts Overall Survival in High-Grade Glioma Patients
    Albert J.S. Idema, Aswin L. Hoffmann, Hieronymus D. Boogaarts, Esther G.C. Troost, Pieter Wesseling, Arend Heerschap, Winette T.A. van der Graaf, J. Andre Grotenhuis and Wim J.G. Oyen
    Journal of Nuclear Medicine December 1, 2012, 53 (12) 1904-1910; DOI: https://doi.org/10.2967/jnumed.112.105544
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire